Greco Oswaldo T, Bittencourt Lia R A, Vargas Remy N A, Borges Moacir A, Mateos José C P, Neto Augusto Cardinalli, Coelho Ormuz D C, Silva Rogério S, Mazzo Rosana A, Melatto Douglas M B, Tufik Sérgio, Gauch Paulo R A
Department of Cardiology, Medical School of São José do Rio Preto, São Paulo, Brazil.
Pacing Clin Electrophysiol. 2006 Feb;29(2):135-41. doi: 10.1111/j.1540-8159.2006.00306.x.
The cardiovascular system (CVS) is heavily influenced by the autonomic nervous system. Additionally, there is a functional alteration during the various stages of sleep. In nonrapid eye movement (NREM), a state of cardiovascular relaxation occurs during stages three and four. A large amount of rapid ocular movements is concentrated in rapid eye movement (REM) sleep. During this phase, fluctuations in arterial pressure (AP) and heart rate (HR) can be readily noted. Sleep disordered breathing (SDB) has been associated with cardiac rhythm disorders. Recently, cardiac rhythm disorder treatment with pacemaker (PM) highlighted a reduction in abnormal respiratory events during sleep.
Comparison of sleep parameters of patients using PM with a sleep rate (SR) algorithm based on its rate-modulated capability during physical activity (Integrity PM with SR function on and off).
Twenty-two patients (14 women, 8 men), implanted with an Integrity PM (St. Jude Medical Cardiac Rhythm Management Division, Sylmar, CA) with SR function for standard clinical indications, were evaluated utilizing a double-blind protocol. The indication for pacing included sinus node disease (SND), atrium ventricular blockage (AVB), and atrial fibrillation (AF). Following randomization, half of our patients had SR function switched to "on" mode while the other half were on "off" mode. During the first stage of the protocol, all patients underwent two consecutive nights of polysomnographic sleep recordings (PSG). During the first night patients slept in the sleep lab only for adaptation purpose. PSG full recording was carried out in the subsequent night. At a later stage, the programing of SR functions was shifted to "on" or "off" modes. One week later, a third assessment was undertaken.
Twelve patients (54%) showed sleep efficiency improvement (total sleeping time/recording time) with PM SR on. This group had the least effective sleep efficiency with PM off, if compared with the others who highlighted no change in this sleep parameter (72 +/- 12 vs 81 +/- 7%, P = 0.01, respectively). This first group displayed a lower latency for REM sleep than the last one (89 +/- 55 vs 174 +/- 107 minutes, P = 0.01, respectively). In 11 (50%) patients, the number per sleep hour of microarousals was reduced when PM SR was switched on. When we compared such findings to the group whose parameters had not changed, we noted that the first set of patients were sleepier (ESE: 9 +/- 4 vs 5 +/- 5, P = 0.04, respectively), and showed more microarousals with PM SR off (20 +/- 14 vs 7 +/- 5 microarousal/hour, P = 0.007).
In PM patients with sleep-related issues, the SR function activation improved sleep both from a qualitative and quantitative perspective.
心血管系统(CVS)受自主神经系统的影响很大。此外,睡眠各阶段存在功能改变。在非快速眼动(NREM)睡眠中,三、四期会出现心血管舒张状态。大量快速眼球运动集中在快速眼动(REM)睡眠阶段。在此阶段,可容易地观察到动脉压(AP)和心率(HR)的波动。睡眠呼吸障碍(SDB)与心律失常有关。最近,起搏器(PM)治疗心律失常突出了睡眠期间异常呼吸事件的减少。
比较使用具有基于身体活动时速率调节能力的睡眠率(SR)算法的PM患者的睡眠参数(Integrity PM的SR功能开启和关闭)。
22例患者(14例女性,8例男性)植入具有SR功能的Integrity PM(圣犹达医疗心脏节律管理部,西尔玛,加利福尼亚州)用于标准临床指征,采用双盲方案进行评估。起搏指征包括窦房结疾病(SND)、房室传导阻滞(AVB)和心房颤动(AF)。随机分组后,一半患者的SR功能切换到“开启”模式,另一半处于“关闭”模式。在方案的第一阶段,所有患者连续两晚进行多导睡眠图睡眠记录(PSG)。第一晚患者仅在睡眠实验室睡觉以适应环境。后续晚上进行PSG全程记录。在后期阶段,SR功能的程控切换到“开启”或“关闭”模式。一周后,进行第三次评估。
12例患者(54%)在PM的SR功能开启时睡眠效率提高(总睡眠时间/记录时间)。与其他睡眠参数无变化的患者相比,该组在PM的SR功能关闭时睡眠效率最低(分别为72±12%和81±7%,P = 0.01)。第一组的REM睡眠潜伏期低于最后一组(分别为89±55分钟和174±107分钟,P = 0.01)。11例(50%)患者在PM的SR功能开启时每睡眠小时的微觉醒次数减少。当我们将这些结果与参数未改变的组进行比较时发现,第一组患者更困倦(ESE:分别为9±与5±5,P = 0.04),并且在PM的SR功能关闭时微觉醒更多(20±14次/小时与7±5次/小时,P = 0.007)。
在有睡眠相关问题的PM患者中,SR功能激活从定性和定量角度均改善了睡眠。